Trial NCT01031628

View at ClinicalTrials.gov 
Org. Study IDs: SARC019
Secondary IDs: STI571BUS286T

Last trial update was posted on 2013-09-09

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Gastrointestinal Stromal Tumors

Other Conditions


Stopping Reasons

Lack of feasibility secondary to slow accrual

Limitations And Caveats

A decision was made to discontinue the SARC019 trial effective March 3, 2011, due to lack of feasibility secondary to slow accrual. Due to early termination of the study, no patients were analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID